Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantation

Published:2020-07-30 Issue:11 Volume:99 Page:2659-2670
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Meng Xing-Ye,Fu Hai-Xia,Zhu Xiao-Lu,Wang Jing-Zhi,Liu Xiao,Yan Chen-Hua,Zhang Yuan-Yuan,Mo Xiao-Dong,Wang Yu,Han Wei,Chen Yu-Hong,Chen Ding-Bao,Liu Hui-Xin,Chang Ying-Jun,Xu Lan-Ping,Liu Kai-Yan,Huang Xiao-Jun,Zhang Xiao-Hui^ORCID

Funder

National Key Research and Development Program of China

Beijing Municipal Science and Technology Commission

National Natural Science Foundation of China

Key Program of National Natural Science Foundation of China

Beijing Natural Science Foundation

Foundation for Innovative Research Groups of the National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-020-04201-4.pdf

Reference50 articles.

1. Ljungman P (2008) CMV infections after hematopoietic stem cell transplantation. Bone Marrow Transplant 42(Suppl 1):S70–s72. https://doi.org/10.1038/bmt.2008.120

2. Liu J, Kong J, Chang YJ, Chen H, Chen YH, Han W, Wang Y, Yan CH, Wang JZ, Wang FR, Chen Y, Zhang XH, Xu LP, Liu KY, Huang XJ (2015) Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality. Clin Microbiol Infect 21(12):1121.e1129–1121.e1115. https://doi.org/10.1016/j.cmi.2015.06.009

3. Green ML, Leisenring W, Xie H, Mast TC, Cui Y, Sandmaier BM, Sorror ML, Goyal S, Ozkok S, Yi J, Sahoo F, Kimball LE, Jerome KR, Marks MA, Boeckh M (2016) Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study. Lancet Haematol 3(3):e119–e127. https://doi.org/10.1016/s2352-3026(15)00289-6

4. Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V, Griffiths PD (2017) Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis 64(1):87–91. https://doi.org/10.1093/cid/ciw668

5. Ljungman P, Griffiths P, Paya C (2002) Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34(8):1094–1097. https://doi.org/10.1086/339329

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and outcomes of immunocompromised critically ill patients with cytomegalovirus end-organ disease: a multicenter retrospective cohort study;Critical Care;2024-07-16

2. Late cytomegalovirus disease after hematopoietic cell transplantation: significance of novel transplantation techniques;Blood Advances;2024-07-11

3. Viral enteritis after allogeneic hematopoietic stem cell transplantation: pathogens, clinical characteristics, and outcomes;2024-07-10

4. LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM?;Mediterranean Journal of Hematology and Infectious Diseases;2024-04-30

5. Clinical features and prognosis of systemic lupus erythematosus complicated by active cytomegalovirus infection: a retrospective cohort study;Frontiers in Immunology;2024-02-28